Grants awarded from the MSCRF are contingent upon the Principal Investigator having obtained all applicable approvals from an Institutional Review Board (IRB), an Institutional Animal Care and Use Committee (IACUC), and having signed an agreement with TEDCO setting forth the scope of each project and the requirements relating to diligent execution of the project, sharing of any new cells lines, publication of results, and the like. The amounts of the awards will be disclosed once final terms are negotiated and the agreements are signed with the Principal Investigators. Research activity can then begin immediately.
The goals of the MSCRF are to broaden and advance basic knowledge of human stem cell biology that will be relevant for eventual development of clinical applications, and to enable, support and accelerate such clinical applications for prevention, diagnosis and treatment of human diseases and conditions. The Commission sought the widest range of research topics that may achieve these goals.
The work funded must be conducted in Maryland. The scientists and clinicians conducting the work must be employed or retained by an eligible Maryland-based organization while doing so. Such employment or retainer may be permanent or temporary, full-time or part-time. All Principal Investigators funded will be required to present their interim and final research results at the Maryland Stem Cell Symposium and in annual reports to the Commission.
About the Maryland St
|SOURCE Maryland Stem Cell Research Commission|
Copyright©2008 PR Newswire.
All rights reserved